Summary: Thiamine derivatives developed initially to treat nutritional deficiencies are drawing renewed interest for their effects on brain function and energy regulation. A recent study from the University of Tsukuba reports that thiamine tetrahydrofurfuryl disulfide (TTFD), a vitamin B1 derivative, raises dopamine levels in the medial prefrontal cortex of rats and promotes increased arousal and physical activity.
The study links TTFD’s behavioral effects to activation of key components of the brain’s ascending arousal system, including the ventral tegmental area (VTA) and the locus coeruleus. These findings indicate that, beyond its established role in nutritional support, TTFD may represent a novel approach to enhancing alertness and daily vitality.
Key Facts:
- Dopamine boost: Administration of TTFD increased dopamine levels in brain regions associated with motivation, decision-making and arousal, notably the medial prefrontal cortex (mPFC).
- Wakefulness and activity: Rats receiving TTFD showed measurable increases in physical activity and wakefulness compared with controls.
- Brain activation: Markers of activation were observed in arousal-related nuclei such as the ventral tegmental area and the locus coeruleus, implicating these regions in TTFD’s behavioral effects.
Source: University of Tsukuba
Background: Thiamine (vitamin B1) deficiency has historically been linked to disorders such as beriberi, a condition that was common in Japan from the Edo through Meiji periods. The development of thiamine derivatives in the mid-20th century provided effective treatments for deficiency, and these compounds have since been used widely as nutritional supplements to support energy metabolism. Although overt deficiency is uncommon in many modern populations, attention has turned to whether thiamine derivatives can influence brain function and behavior beyond correcting deficiency.
Recent preclinical work has explored how thiamine derivatives affect neural circuits involved in motivation, movement and sleep-wake regulation. The research team at the University of Tsukuba previously reported that TTFD increases dopamine in the mPFC and thereby enhances spontaneous physical activity in rats. Building on that work, the team hypothesized that TTFD might also promote arousal via dopaminergic pathways and other elements of the ascending arousal network.
To investigate this hypothesis, researchers administered TTFD intraperitoneally to rats and recorded electroencephalogram (EEG) and electromyogram (EMG) signals to track sleep-wake states and muscle activity. They simultaneously monitored locomotor activity to quantify behavioral changes. Detailed analysis showed that TTFD produced an acute increase in wakefulness and concomitant reductions in slow-wave sleep (SWS) and rapid eye movement (REM) sleep, while increasing physical activity during the observation period.
The observed increase in wakefulness appears to be associated with activation of arousal centers, including the ventral tegmental area and locus coeruleus, which are known to influence dopamine signaling and the sleep-wake cycle. These results suggest a mechanism by which TTFD could enhance both motivation-related behavior and overall alertness through modulation of dopaminergic and noradrenergic systems.
While these findings are based on controlled experiments in rodents and further research is needed to clarify the precise neural circuitry and translational potential, the study highlights TTFD as a promising candidate for supporting daily vitality and mental alertness. Future work planned by the team will aim to map the specific neural mechanisms responsible for the arousal-promoting effects and to evaluate the duration, dose-dependence and safety profile of TTFD in more detail.
Funding: This research received partial funding from multiple sources, including KAKENHI Grants-in-Aid for Scientific Research (A) (21H04858; 24H00670) (H. Soya); Scientific Research (C) (22K11601) (F. Grenier); Scientific Research on Innovative Areas (16H06405) (H. Soya); Japan Science and Technology Agency (JST)-Mirai Program (JPMJMI19D5) (H. Soya); Grant-in-Aid for Japan Society for the Promotion of Science Fellowships (21J20478; 22KJ0362) (T. Hata); and a joint research grant from NIHON PHARMACEUTICAL Co., Ltd (H. Soya).
About this dopamine and wakefulness research news
Author: H. Soya
Source: University of Tsukuba
Contact: H. Soya – University of Tsukuba
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Promoting arousal associated with physical activity with the vitamin B1 derivative TTFD” by H. Soya et al., Journal of Physiological Sciences.
Abstract
Promoting arousal associated with physical activity with the vitamin B1 derivative TTFD
Physical inactivity is a widespread public health concern that undermines both physical and mental vitality, particularly affecting functions that rely on the prefrontal cortex. Reduced activity and impaired prefrontal cortex function can contribute to social withdrawal and depressive symptoms, making it harder to maintain an active lifestyle.
In this study, the researchers identified a beneficial effect of the vitamin B1 derivative thiamine tetrahydrofurfuryl disulfide (TTFD), which enhances physical activity via dopaminergic modulation in the medial prefrontal cortex (mPFC) of rats. Given the role of the brain’s dopaminergic system in regulating the sleep-wake cycle through the ascending arousal network, the team evaluated whether TTFD would also promote wakefulness.
Using EEG and EMG recordings combined with behavioral monitoring, the investigators found that acute TTFD administration promoted arousal, decreased slow-wave and REM sleep, and increased locomotor activity. These effects indicate that TTFD can both stimulate physical activity and enhance alertness, suggesting potential benefits for mental vitality. Ongoing and future studies will further explore the neural pathways involved and the implications for supporting daily energy and mental health.